InvestorNewsBreaks

Wednesday May 21, 2025 - 1:30 pm

InvestorNewsBreaks – Trump Media & Technology Group Corp. (NASDAQ: DJT) Faces Scrutiny After AG Pam Bondi’s Stock Sale

Trump Media & Technology Group (NASDAQ: DJT) is under scrutiny following revelations that U.S. Attorney General Pam Bondi sold between $1 million and $5 million worth of the company's shares on April 2, 2025—the same day President Donald Trump announced significant new tariffs that led to a market downturn. Bondi's financial disclosure forms indicate the transactions occurred on that date, though it's unclear whether they…

Wednesday May 21, 2025 - 1:28 pm

InvestorNewsBreaks – Meta Platforms Inc. (NASDAQ: META) Expands ‘Below Expectations’ Ratings in Midyear Reviews

Meta Platforms (NASDAQ: META) is intensifying its performance management strategy by instructing managers to classify a higher percentage of employees as "below expectations" in the 2025 midyear reviews. According to an internal memo, teams with 150 or more members are now expected to rate 15% to 20% of employees in this lowest performance tier, up from the previous 12% to 15%. This adjustment includes staff…

Wednesday May 21, 2025 - 10:10 am

InvestorNewsBreaks – SKYX Platforms Corp. (NASDAQ: SKYX) Selected for $3B Smart City Development in Miami

SKYX Platforms (NASDAQ: SKYX) announced a major collaboration with SG Holdings for a $3 billion smart city development in Miami’s Little River District. The company will deploy over 500,000 units of its patented plug-and-play smart home technologies across 5,700 planned residences, including affordable housing. SKYX’s platform will power safety and smart features such as voice and app controls, 911 emergency calling, smoke and CO detectors,…

Wednesday May 21, 2025 - 10:00 am

InvestorNewsBreaks – Lelantos Holdings, Inc. (OTC PINK: LNTO) Unveils 2025 Renewable Energy Strategy with Focus on Veterans, Underserved Communities, and Credit Innovation

Lelantos Holdings (OTC PINK: LNTO)  announced a comprehensive 2025 strategy through its subsidiary, Lelantos Energy, aimed at expanding renewable energy access, advancing credit monetization, and serving underserved communities. Key initiatives include a partnership with NeRD Power for turnkey commercial solar projects, the launch of Free Solar 4 Veterans with The Warrior Up Foundation, and a Sustainable Community Network to bring no-cost solar to over 550…

Wednesday May 21, 2025 - 10:00 am

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Secures $3M Equity Investment to Advance Age-Reversal Pipeline

Telomir Pharmaceuticals (NASDAQ: TELO) announced a $3 million equity investment from The Bayshore Trust, the company’s largest shareholder, through the purchase of 1 million restricted shares at $3.00 each—an 18% premium to the stock’s prior closing price. The raise brings total equity investment from affiliated entities to $4 million, complemented by an undrawn $5 million non-dilutive credit line. CEO Erez Aminov emphasized the company’s commitment…

Wednesday May 21, 2025 - 10:00 am

InvestorNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Begins Gold and Silver Processing from Talisker, Prepares for Multi-Source Production Ramp-Up

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) has begun receiving and processing high-grade gold and silver ore from Talisker Resources at its upgraded $33 million Merritt Mill in British Columbia, the province’s only facility permitted to accept third-party precious metal feed. Production is expected to reach full capacity in Q3 2025, and Nicola has initiated a permit amendment to expand mill throughput. The Company…

Wednesday May 21, 2025 - 9:50 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with Nasal Spray Device Study for SPC-15

Silo Pharma (NASDAQ: SILO) announced a service agreement with Resyca BV to conduct a drug-device study on the microchip-enabled nasal spray system used in its lead PTSD treatment candidate, SPC-15. The study is intended to provide the final device data needed for an Investigational New Drug (IND) application to the FDA later this year. CEO Eric Weisblum noted the device’s ability to bypass the blood-brain…

Wednesday May 21, 2025 - 9:30 am

InvestorNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Launches UnGPT.ai to Transform AI-Generated Text into Humanlike Content

Gaxos.ai (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, announced the official launch of UnGPT.ai, a real-time rewriting tool that converts machine-generated text into natural, human-quality content without compromising meaning. UnGPT leverages a proprietary multi-pass transformation model to deliver undetectable, high-quality output, outperforming leading AI detection tools. The platform includes features such as an adaptive text engine for tone tuning, contextual synonym…

Wednesday May 21, 2025 - 9:30 am

InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Doses First Patient in DoD-Backed OASIS Trial for Acute Stress Reaction

Tonix Pharmaceuticals (NASDAQ: TNXP) announced the first patient has been dosed in the Phase 2 OASIS trial evaluating TNX-102 SL for reducing acute stress reaction (ASR) severity and the onset of acute stress disorder (ASD). Sponsored by the University of North Carolina’s Institute for Trauma Recovery and backed by a $3 million U.S. Department of Defense grant, the trial will enroll about 180 motor vehicle…

Wednesday May 21, 2025 - 9:20 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Taps BitGo to Safeguard Crypto Assets

Quantum BioPharma (NASDAQ: QNTM) has partnered with BitGo Trust Company to provide secure, institutional-grade custody for its Bitcoin, Solana, XRP, and DOGE holdings. The biopharmaceutical company, which is building a portfolio of innovative biotech assets, cited security and compliance as key drivers behind the selection of BitGo, known for its multi-signature wallets, cold storage solutions, and insurance-backed infrastructure. CEO Zeeshan Saeed said the partnership strengthens Quantum’s…

Wednesday May 21, 2025 - 9:10 am

InvestorNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Launches 2025 Exploration Program at Storm Copper Project

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) announced plans for its 2025 regional exploration program at the Storm Copper Project on Somerset Island, Nunavut, operated by American West Metals under a 20/80 joint venture in which Aston Bay holds a free carried interest until a mine decision is made. CEO Thomas Ullrich highlighted key 2025 milestones, including the completion of an NI 43-101 Initial Mineral Resource…

Wednesday May 21, 2025 - 9:10 am

InvestorNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands Global Reach with Juve Stabia Playoff Match Streaming in U.S., Canada, UK

Brera Holdings (NASDAQ: BREA) announced that S.S. Juve Stabia’s Serie B semifinal playoff match against Cremonese will stream live and air free today in the U.S., Canada and UK via Destination Calcio TV, with full English commentary. The broadcast reflects Brera’s commitment to internationalizing its portfolio club's exposure as part of its multi-club ownership strategy. Executive Chairman Daniel McClory emphasized that expanding Juve Stabia’s global…

Wednesday May 21, 2025 - 9:00 am

InvestorNewsBreaks – OMS Energy Technologies (NASDAQ: OMSE) Secures $33M in IPO

OMS Energy Technologies (NASDAQ: OMSE) is a growth-oriented manufacturer of surface wellhead systems and oil country tubular goods for the oil and gas industry. The company recently closed its initial public offering of 3,703,704 ordinary shares, each at a public offering price of US$9.00, for a total base size of US$33.3 million. The ordinary shares began trading on the Nasdaq Capital Market under the symbol…

Wednesday May 21, 2025 - 9:00 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Wall Street Conference on May 21

NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced that Founder and CEO Dr. Jonathan Javitt will deliver a company update at the Wall Street Conference on May 21, 2025, in Palm Beach, Florida. NRx is one of six companies invited to present at the high-profile event, which is expected to draw more than 1,000 attendees representing over $1 trillion in investment capital. The presentation…

Tuesday May 20, 2025 - 10:55 am

InvestorNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Appoints Frank Knuettel II to Board of Directors

Beeline Holdings (NASDAQ: BLNE)  announced the appointment of Frank Knuettel II to its board of directors, effective immediately. Knuettel brings over 20 years of executive leadership experience across early-stage public companies in technology and life sciences, and currently serves as CEO of Channel Therapeutics Corporation. Known for his capital markets expertise and M&A success, including leading Unrivaled Brands from $10 million to $100 million in…

Tuesday May 20, 2025 - 9:30 am

InvestorNewsBreaks – VERAXA Biotech AG Appoints Dr. Rick Austin as Chief Scientific Officer

VERAXA Biotech AG, a cancer therapy innovator, and proposed de-SPAC target of Voyager Acquisition Corp. (NASDAQ: VACH), announced the appointment of Rick Austin, Ph.D., as Chief Scientific Officer, effective May 1. Dr. Austin brings more than 25 years of oncology research and development leadership and will help drive VERAXA’s BiTAC(TM) platform and clinical-stage pipeline. He previously served as VP of Research at Harpoon Therapeutics (acquired…

Tuesday May 20, 2025 - 9:20 am

InvestorNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Named Exclusive UK and EEA Distributor for ZOLEO Satellite Devices

NextPlat (NASDAQ: NXPL, NXPLW) announced that its subsidiary, Global Telesat Communications Ltd (GTC), has been appointed the exclusive distributor for ZOLEO Inc. across the UK and European Economic Area. ZOLEO's flagship global satellite communicator extends smartphone messaging coverage via the Iridium(R) satellite network and has earned accolades including Outdoor Retailer’s Innovation Award "Product of the Year." The partnership adds to GTC’s expanding e-commerce and Amazon…

Tuesday May 20, 2025 - 9:15 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Posts $5M Q2 Revenue, Highlights EV Deliveries and Battery Progress

Mullen Automotive (NASDAQ: MULN) reported $5 million in revenue for the quarter ended March 31, 2025, a significant increase from $33,000 in the prior-year period, driven by deliveries of Class 1 and Class 3 electric vehicles to customers including logistics firms, local governments and universities. The company also highlighted new agreements, such as a supply deal with Enpower Greentech for advanced solid-state batteries and expanded…

Tuesday May 20, 2025 - 9:10 am

InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Signs Agreement to Advance MS Drug Toward Phase 2 Trial

Quantum BioPharma (NASDAQ: QNTM) has signed an agreement with a global pharmaceutical contract research organization to prepare an Investigational New Drug (IND) application for its lead compound, Lucid-21-302 (Lucid-MS), targeting multiple sclerosis. The IND submission to the FDA is planned for the fourth quarter of 2025 and, if accepted, would enable the company to initiate a Phase 2 clinical trial. Lucid-21-302 is a patented, non-immunomodulatory neuroprotective…

Tuesday May 20, 2025 - 9:05 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Applauds FDA Support for Psychedelic Therapeutics, Advances Phase 3 Trials

Cybin (NYSE American: CYBN) (NEO: CYBN) welcomed recent comments from FDA Commissioner Dr. Martin Makary endorsing the accelerated development of psychedelic therapeutics. The company, which is conducting Phase 3 trials of CYB003 for major depressive disorder (MDD) and Phase 2 trials of CYB004 for generalized anxiety disorder (GAD), said the FDA’s openness validates its mission to develop next-generation neuropsychiatric treatments. CYB003, a deuterated psilocin candidate,…

Tuesday May 20, 2025 - 9:00 am

InvestorNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Finalizes CSI Acquisition, Projects Strong Revenue Growth

Datavault AI (NASDAQ: DVLT), a leader in AI-powered data experience, valuation and monetization, announced it expects to finalize the acquisition of CompuSystems Inc. (CSI) assets today, May 20, 2025. In conjunction with the milestone, the company will host a business update call at 9 a.m. ET. CEO Nathaniel Bradley said the acquisition marks a pivotal step in Datavault’s growth strategy, positioning it to automate and…

Tuesday May 20, 2025 - 9:00 am

InvestorNewsBreaks – Thumzup Media Corp. (NASDAQ: TZUP) to Present at 82nd Emerging Growth Conference on May 21

Thumzup (NASDAQ: TZUP) announced that CEO Robert Steele will present at the 82nd Emerging Growth Conference on May 21, 2025, at 11:25 a.m. ET. The company will showcase its disruptive platform that pays everyday consumers to post about participating brands on social media, enabling scalable, user-generated advertising. Hosted virtually, the conference highlights innovative small- and micro-cap companies positioned for long-term growth. To view the full…

Monday May 19, 2025 - 9:02 am

InvestorNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Terminates Acquisition Agreement with Appili Therapeutics

Aditxt (NASDAQ: ADTX), a social innovation platform advancing health innovations, announced its decision to terminate the Arrangement Agreement with Appili Therapeutics Inc., effective May 31, 2025. The agreement, first announced in April 2024, had been amended multiple times to address evolving conditions. Aditxt cited a lack of strategic alignment as the reason for discontinuing the deal, despite ongoing respect for Appili’s work. Management plans to…

Monday May 19, 2025 - 9:02 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Expands Remote Workforce Testing with Fingerprint Drug Screening in Australia

Intelligent Bio Solutions (Nasdaq: INBS), a medical technology company focused on rapid, non-invasive testing, successfully completed a full workforce drug screening for Barcaldine Regional Council in Queensland, Australia, using its Intelligent Fingerprinting Drug Screening System. Over 160 employees were tested and cleared within 90 minutes, significantly reducing operational disruption compared to traditional methods. The on-site, fingerprint-based solution enabled same-day results and supported immediate workforce return, highlighting…

Monday May 19, 2025 - 9:00 am

InvestorNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) posted fiscal Q3 results for the period ended March 31, 2025, showing year-to-date revenue of C$29.1 million versus C$50.4 million a year earlier, reflecting a shift toward long-term asset ownership over short-term EPC sales. The company reported a net loss of C$9 million compared to net income of C$5.5 million last year, driven by…

Monday May 19, 2025 - 9:00 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants

Silo Pharma (NASDAQ: SILO) a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, closed a public offering totaling approximately $2 million in gross proceeds. The offering included 3,333,338 shares of common stock or pre-funded warrants, along with Series A-1 and Series A-2 warrants, each allowing the purchase of up to 3,333,338 shares at $0.60 per share. The Series A-1 Warrants expire…

Friday May 16, 2025 - 2:10 pm

InvestorNewsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Reaffirms 2025 Guidance, Highlights M&A Pipeline and Flexible Growth Strategy

Capstone Holding (NASDAQ: CAPS)  reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track…

Friday May 16, 2025 - 10:28 am

InvestorNewsBreaks – Bionoid Pharma Inc. (OTC PINK: BINP) Rebrands as AI Maverick Intel to Focus on AI-Driven Engagement

Bionoid Pharma (OTC PINK: BINP)  has rebranded as AI Maverick Intel, Inc., signaling a strategic pivot toward artificial intelligence-powered customer acquisition and engagement solutions. The transformation follows the acquisition of AI Maverick Intel, a platform specializing in AI-based audience automation and intelligent two-way communication. The company aims to deploy its proprietary technology across healthcare, biotech, and other sectors to enhance targeting, engagement, and operational efficiency. …

Friday May 16, 2025 - 10:00 am

InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Expands to Indonesia with AI Insurance Platform Through Mach Wireless Deal

FingerMotion (NASDAQ: FNGR), has entered the Indonesian market via its subsidiary, Finger Motion Financial Company Limited, by signing an agreement with PT Mach Wireless Teknologi to deploy its AI-driven insurance risk rating platform. Tailored for local underwriting in motor, health, and life insurance, the platform will integrate with Indonesia’s telco-insurance ecosystem. The company is in final talks with a major Indonesian telecom provider to support…

Friday May 16, 2025 - 9:35 am

InvestorNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer

CNS Pharmaceuticals (NASDAQ: CNSP) reported a Q1 2025 net loss of $4.3 million, up from $3.5 million in the prior year period, as R&D spending increased to support data analysis for its Berubicin trial. The company remains focused on advancing TPI 287, a novel taxane with the potential to treat glioblastoma by crossing the blood-brain barrier. CNS has secured Orphan Drug Designation for TPI 287…

Friday May 16, 2025 - 9:20 am

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) Advances NV-387 Antiviral Program, Prepares for Multiple Phase II Trials

NanoViricides, Inc. (NYSE American: NNVC) filed its Q1 2025 report and announced progress on NV-387, its broad-spectrum antiviral drug candidate. The company has received clearance from the DRC's National Ethics Committee to submit a Phase II trial application for MPox and is also initiating programs targeting measles and avian flu. NV-387 previously completed Phase I with no adverse events and has shown superior activity in…

Friday May 16, 2025 - 9:10 am

InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Prices $2 Million Public Offering of Common Stock and Warrants

Silo Pharma (NASDAQ: SILO) has priced a public offering of approximately 3.33 million shares of common stock (or pre-funded warrants) along with Series A-1 and Series A-2 warrants, all priced at $0.60 per unit. The Series A-1 and A-2 warrants are immediately exercisable at $0.60 per share, with expirations set at five years and eighteen months, respectively. Gross proceeds are expected to total roughly $2…

Friday May 16, 2025 - 9:00 am

InvestorNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) CEO Highlights Vertical Integration and $184M Asset Base on GotStocks Podcast

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) President and CEO Dr. Richard Lu appeared on the GotStocks Podcast to discuss the company’s vertically integrated model and its $184 million portfolio of revenue-generating clean energy assets. Lu detailed how SolarBank develops, builds, owns, and operates distributed and community solar projects across Canada and the U.S., including partnerships with Honeywell and Qcells. He…

Friday May 16, 2025 - 9:00 am

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q1 Results, Highlights Progress on Ketamine NDA and HOPE Clinic Rollup

NRx Pharmaceuticals (NASDAQ: NRXP) reported a Q1 2025 net loss of $5.5 million, down from $6.5 million in the same period last year, with operating losses narrowing to $3.8 million. The company advanced regulatory and commercial milestones for its two lead programs: NRX-100, a preservative-free IV ketamine formulation for suicidal depression now supported by an NDA fee waiver and new patent filing; and NRX-101, an…

Thursday May 15, 2025 - 3:36 pm

InvestorNewsBreaks – Adageis’ Fintech Platform Drives Smarter, More Profitable Healthcare

Adageis, a forward-thinking healthcare technology company, is empowering clinics and medical groups to succeed in the shift from fee-for-service to value-based care through its AI-powered platform. The company’s ProActive Care solution deciphers complex insurance contracts, integrates with leading EHR systems, and offers real-time analytics to help providers track revenue trends as well as their performance and profitability. Proprietary components of the platform, including the Value-Based…

Thursday May 15, 2025 - 2:32 pm

InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Strengthens Pharma Footprint Through Key Alliances

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, is expanding its market presence and manufacturing capabilities through two new strategic partnerships. The company is collaborating with Charlotte FC to build brand visibility, particularly for its AI Tape and AVERSA(TM)—Nutriband’s proprietary technology that it believes has the potential to be the world’s first and only abuse deterrent patch…

Thursday May 15, 2025 - 12:54 pm

InvestorNewsBreaks – Zacks Research Issues Business Update as Soligenix Inc. (NASDAQ: SNGX) Continues Enrollment in Confirmatory Phase 3 HyBryte Trial

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company targeting rare diseases, was spotlighted this week in a Zacks Small-Cap Research report that presented a favorable analysis, noting that the company’s Phase 3 cutaneous T-cell lymphoma (“CTCL”) study is continuing and that the trial has a high probability of success. According to the report, Soligenix is conducting a Phase 3 FLASH2 trial of HyBryte(TM) in patients with…

Thursday May 15, 2025 - 12:30 pm

InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Secures $7.8M to Launch Clinic Rollup Strategy

NRx Pharmaceuticals (NASDAQ: NRXP) announced that its wholly owned subsidiary, HOPE Therapeutics(TM), has signed a term sheet with Universal Capital, LLC for $7.8 million in acquisition funding to support the rollout of its national interventional psychiatry clinic network. Combined with previously announced investments, HOPE now has $10.3 million in capital to execute initial acquisitions of Dura Medical, Kadima, and NeuroSpa. These clinics offer neuroplastic treatments…

Thursday May 15, 2025 - 10:10 am

InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally

Intelligent Bio Solutions (NASDAQ: INBS) reported continued commercial growth, surpassing 450 active accounts with 35 added in fiscal Q3, driven by demand for its rapid, non-invasive fingerprint drug testing system. The company expanded into new sectors including luxury marine, retail, and waste management, while entering remote regions across Europe and Australia. INBS now operates in 24 countries and partners with 18 distributors across 19 nations.…

Thursday May 15, 2025 - 10:00 am

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Unveils Breakthrough Silver(II) Antimicrobial Drug Candidate Telomir-Ag2

Telomir Pharmaceuticals (NASDAQ: TELO) announced the identification of Telomir-Ag2, a stabilized Silver(II) complex demonstrating potent, broad-spectrum antimicrobial activity, including against drug-resistant MARSA. Developed using the company’s proprietary Telomir-1 platform, Telomir-Ag2 is the first Silver(II) compound to achieve biological compatibility, outperforming its Silver(I) predecessor in preclinical studies. Designed for use in high-risk infections such as burns and surgical wounds, the drug candidate targets the growing $1.36…

InvestorNewsBreaks

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions